Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers
NCT00002231 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
The purpose of this study is to see if it is safe to give GENEVAX-HIV, a new HIV vaccine, to HIV-negative volunteers. This study will also look at how this vaccine affects the immune system of these volunteers.
Conditions
- HIV Infections
- HIV Seronegativity
Interventions
- BIOLOGICAL
-
APL 400-003
Sponsors & Collaborators
-
Wyeth-Lederle Vaccines
lead INDUSTRY
Principal Investigators
-
RR MacGregor
Study Design
- Purpose
- PREVENTION
- Masking
- NONE
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Study to Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines
NCT04586673 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults
NCT01438606 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults
NCT01964937 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
NCT00002441 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population
NCT05580458 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers
NCT00490074 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
NCT01428596 ·Status: UNKNOWN ·Phase: PHASE1
-
A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants
NCT00000829 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected Adults
NCT01799954 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults
NCT01260727 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults
NCT00415649 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults
NCT00043511 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults
NCT01970449 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus
NCT00000683 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials
NCT00029913 ·Status: COMPLETED
-
Study to Evaluate the Safety and Immunogenicity of an Oral HIV Vaccine in Healthy, HIV-uninfected Adults
NCT02771730 ·Status: TERMINATED ·Phase: PHASE1
-
Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults
NCT00270218 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
NCT01989533 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety, Tolerability, and Immunogenicity of a Prime-Boost Regimen of HIV-1 Nef/Tat/Vif, Env pDNA Vaccine Delivered Intramuscularly With Electroporation and HIV-1 rVSV envC Vaccine in Healthy, HIV-Uninfected Adults
NCT02654080 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults
NCT00051454 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults
NCT02296541 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults
NCT00000904 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm
NCT00076817 ·Status: COMPLETED ·Phase: PHASE1
-
Candidate HIV Vaccine
NCT00089531 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients
NCT00002350 ·Status: COMPLETED ·Phase: PHASE1